386 filings
Page 18 of 20
6-K
wb9v9
5 Apr 17
Report of Foreign Private Issuer
12:00am
6-K
kjxwv
5 Apr 17
Therapix Signs Exclusive License Agreement with Yissum for Nasal Drug Delivery Technology
12:00am
6-K
3tijgrn23za6 vs2m5k
3 Apr 17
Therapix Biosciences Ltd. Announces Full Exercise of Underwriters’ Over-Allotment Option
12:00am
6-K
b8lre
28 Mar 17
Therapix Biosciences Ltd. Announces Closing of U.S. Initial Public Offering of American Depositary Shares
12:00am
424B4
kbk63
22 Mar 17
Prospectus supplement with pricing info
12:00am
CT ORDER
0vrodx xaa6ww
22 Mar 17
Confidential treatment order
12:00am
8-A12B
5x1uce
21 Mar 17
Registration of securities on exchange
12:00am
EFFECT
0wup4err3xbd8ofpdt5
21 Mar 17
Notice of effectiveness
12:00am
CORRESP
jjbdrrr6wi56r
20 Mar 17
Correspondence with SEC
12:00am
F-1/A
a639fsgq56s xe9y6uvz
20 Mar 17
Registration statement (foreign) (amended)
12:00am
CORRESP
b9wy1lv4
20 Mar 17
Correspondence with SEC
12:00am
CORRESP
bmy195241
20 Mar 17
Correspondence with SEC
12:00am
UPLOAD
4fmigkcoo5a
20 Mar 17
Letter from SEC
12:00am
FWP
u3ncjctdy u2s9
20 Mar 17
Free writing prospectus
12:00am
F-1/A
5a9w5jys9c0n
15 Mar 17
Registration statement (foreign) (amended)
12:00am
CORRESP
1ineb14xtmjyqohh5eh
14 Mar 17
Correspondence with SEC
12:00am
UPLOAD
gre56f6s1tvby9b6
13 Mar 17
Letter from SEC
12:00am
F-1/A
64uypv84jrxsysov1
3 Mar 17
Registration statement (foreign) (amended)
12:00am
CORRESP
7vc9gmvs1el8k13ufcu
20 Dec 16
Correspondence with SEC
12:00am
F-1/A
elzvy9q kx4
20 Dec 16
Registration statement (foreign) (amended)
12:00am